Abdul B. Wardak
Kabul, KAB, Afghanistan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Lost History of Cardiac Surgery in Afghanistan: Establishment, Evolution, Halt, and Reemergence.
The Lost History of Cardiac Surgery in Afghanistan: Establishment, Evolution, Halt, and Reemergence.
Journal: The Annals of thoracic surgery
Published: September 28, 2025
A large asymptomatic Thornwaldt's cyst incidentally discovered in a patient with chronic kidney disease: a case report and review of clinical implications.
Journal: Annals of medicine and surgery (2012)
Published: March 10, 2025
The potential of CRISPR-Cas9 in cardiovascular medicine: a focus on hereditary cardiomyopathies.
Journal: Annals of medicine and surgery (2012)
Published: September 22, 2024
Revolutionizing anemia management in dialysis: unveiling the potential of FDA-approved Vadadustat for chronic kidney disease (CKD) patients.
Journal: Annals of medicine and surgery (2012)
Published: August 09, 2024
Unmasking pseudopelade of Brocq in male adult: a rare case report.
Journal: Annals of medicine and surgery (2012)
Published: August 08, 2024
Enhancing survival in cardiac arrest: the urgent need for optimized extracorporeal cardiopulmonary resuscitation implementation and protocols - editorial.
Journal: Annals of medicine and surgery (2012)
Published: August 01, 2024
Elafibranor: a breakthrough therapy revolutionizing primary biliary cholangitis (PBC) treatment.
Journal: Annals of medicine and surgery (2012)
Published: July 27, 2024
Crovalimab: a new era in paroxysmal nocturnal hemoglobinuria management.
Journal: Annals of medicine and surgery (2012)
Published: July 22, 2024
Nogapendekin alfa inbakicept-PMLN: first approval milestone for BCG-unresponsive noninvasive bladder cancer: editorial.
Journal: Annals of medicine and surgery (2012)
Published: July 04, 2024
Mavorixafor, CXCR4 antagonist, a novel treatment for WHIM syndrome, first FDA approval 2024.
Journal: Annals of medicine and surgery (2012)
Published: July 04, 2024
FDA approves Resmetirom: groundbreaking treatment for NASH liver scarring in moderate to advanced fibrosis.
Journal: Annals of medicine and surgery (2012)
Published: July 04, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026